GEA Group Aktiengesellschaft · XETR:G1A
GEA Group Aktiengesellschaft — GEA Group — Q3 2026 Earnings Presentation
37 slides from GEA Group Aktiengesellschaft's earnings presentation, Nov 9, 2026
Slide 1: Q3 2026 Results
Q3 2026 Results Stefan Klebert, CEO Alexander Kocherscheidt, CFO Düsseldorf, November 9, 2026
Slide 2: Disclaimer
Disclaimer This presentation contains forward-looking statements. Forward-looking statements may include, in particular, statements about future events, future financial performance, plans, strategies, expectations, prospects, competitive environment, regulation and supply and demand. Statements wit
Slide 3: Highlights Q3 2026
Highlights Q3 2026 Stefan Klebert, CEO Q3 2026 Results 3
Slide 4: Executive Summary Q3 2026
Executive Summary Q3 2026 Significant order intake growth, strong sales development & further EBITDA1 margin expansion Δ Δ €m Q3 26 Q3 25 reported organic Large order (>€15m) volume of €295m vs. large order volume of Order intake 1,651 1,372 20.3% 19.5% €64m in Q3 25; strong growth in base orders St
Slide 5: Share buyback of €500m until 2027
Share buyback of €500m until 2027 1st tranche of €250m to end in Q1 2027 €58.3m €500m Executed² Total program 11.7% As of September 30, 2026¹ Shares repurchased Average purchase price 893.3k €65.32 0.55% of outstanding shares3 per share 1 As of November 6th €91.6m executed, so 18.3% of the total has
Slide 6: Continuous tableting is increasingly gaining traction
Continuous tableting is increasingly gaining traction From proven commercial use to broader adoption 2019–2023 2024–2025 Q3 2026 MISSION 30 R&D SYSTEMS F OLLOW-O N ORDER S COMMERC IA L SCALE GROWT H OU TLOOK Multiple R&D systems Multiple orders secured for Several lines sold for Expected sales CAGR
Slide 7: From days to hours: Continuous tableting is a game changer
From days to hours: Continuous tableting is a game changer TRADITIONAL BATCH 1 2 3 4 5 6 7 8 Usually 8 steps Sequential operations • intermediate storage • testing and release at the end • separate rooms • long production time CONTINUOUS Powder in → integrated powder-to-tablet process → tablet out O
Slide 8: Business & Financial Review Q3 2026
Business & Financial Review Q3 2026 Alexander Kocherscheidt, CFO Q3 2026 Results 8
Slide 9: GEA Group
GEA Group Q3 26: Strong top-line growth & another meaningful EBITDA1 margin increase % Organic change 13.7% Order Intake, €m Organic order intake 19.5% YoY 12.3% − Organic order intake growth in all divisions 4,600 1,828 1,651 − Growth in almost all customer industries, especially Dairy 4,096 1,45
Slide 10: Division Pure Flow Processing (PFP)
Division Pure Flow Processing (PFP) Q3 26: Strong improvement in all KPIs % Organic change 10.4% Order Intake, €m Organic order intake 8.3% YoY 9.0% − Strong development in orders below €5m 1,642 501 514 551 544 548 − Growth has been broad-based; biggest contribution were 1,506 coming from custome
Slide 11: Division Nutrition Plant Engineering (NPE)
Division Nutrition Plant Engineering (NPE) Q3 26: Very strong order intake growth, further pick-up in sales & profitability % Organic change Order Intake, €m Organic order intake 37.6% YoY 24.5% 23.4% − Large order (>€15m) volume of €192m in Dairy Processing 835 1,650 and Beverage vs. large order
Slide 12: Division Pharma & Food Applications (PFA)
Division Pharma & Food Applications (PFA) Q3 26: Large order volume >€100m & substantial YoY EBITDA1 margin improvement % Organic change Order Intake, €m Organic order intake 20.2% YoY 5.6% − Large order (>€15m) volume of €103m in Pharma vs. 3.8% 270 308 274 323 no large order last year 831 801 23
Slide 13: Division Farm Technologies (FT)
Division Farm Technologies (FT) Q3 26: Solid organic order intake development & strong organic sales growth % Organic change Order Intake, €m Organic order intake 4.1% YoY 9.8% - Growth driven by strong demand for service in all regions 8.7% 205 241 236 230 215 - €2m positive FX translation effect
Slide 14: Strong EBITDA performance in 9M and Q3 2026
Strong EBITDA1 performance in 9M and Q3 2026 Positive contribution by all divisions in both time periods 9M 26 EBITDA1 growth contribution by divisions in €m Q3 26 EBITDA1 growth contribution by divisions in €m 261 -6 717 0 -1 16 9 21 6 8 15 32 647 232 EBITDA PFP NPE PFA FT Other / EBITDA EBITDA PFP
Slide 15: Net Working Capital performance
Net Working Capital performance NWC/sales ratio comfortably within the guided corridor ▪ YoY NWC reduction due to a combination of higher contract liabilities (advance payments) and higher trade payables ▪ NWC ratio with 7.8% within the guided corridor of 7.0 – 9.0% 1,000 €m 20% 900 €m 15% 800 €m (i
Slide 16: Good cash generation
Good cash generation FCF Free Cash Flow Q3 26, €m ▪ NWC -€52m: outflow mainly driven by -52 higher trade receivables -36 -5 12 ▪ Positive FCF of €135m -46 261 1 -18 -5 180 135 111 EBITDA Delta NWC Taxes Cash-out Others Operating Capex Others Free Cash Lease Interests Net Cash before Restructuring Ca
Slide 17: Strong cash conversion of 61% in L4Q
Strong cash conversion1 of 61% in L4Q Free Cash Flow 9M 26, €m FCF generation during L4Q per Q3 26, €m 135 -269 -190 151 -90 717 -14 566 -104 470 -118 240 -27 95 -51 -17 27 EBITDA Delta NWC Taxes Cash-out Others Operating Capex Others Free Cash Lease Interests Net Cash Q4 25 Q1 26 Q2 26 Q3 26 Q3 26
Slide 18: Outlook FY 2026
Outlook FY 2026 Stefan Klebert, CEO Q3 2026 Results 18
Slide 19: Guidance for FY 2026 confirmed
Guidance for FY 2026 confirmed Organic sales growth EBITDA margin ROCE1 (currency and portfolio adjusted) (Before restructuring expenses) (Before restructuring expenses) % YoY % % 6.0-8.0 17.0-17.4 36.0-40.0 (FY 2025: 3.7%) (FY 2025: 16.5%) (FY 2025: 36.2%) For divisional guidance, please refer to s
Slide 20: Roadmap for remainder of 2026 and 2027
Roadmap for remainder of 2026 and 2027 March 08, April 28, May 10, Aug 09, Nov 08, Today 2027 2027 2027 2027 2027 Q3 FY AGM Q1 Q2 Q3 2026 2026 FY 2026 2027 2027 2027 Q3 2026 Results 20
Slide 21: Appendix
Appendix Q3 2026 Results 21
Slide 22: GEA – Q3 2026 figures
GEA – Q3 2026 figures Sales by Customer Industry (L4Q) [in €m] Q3 25 Q3 26 Δ YoY L4Q Q3 25 L4Q Q3 26 Δ YoY Order Intake 20,3% 12,9% 1.372,4 1.650,7 5.694,4 6.427,3 Organic1 19,5% 14,9% 14% Dairy Farming 12% YoY 16% Dairy Processing 21% YoY Sales 7,0% 5,4% Food 1% YoY 1.365,9 1.461,2 5.443,9 5.736,1
Slide 23: Pure Flow Processing – Q3 2026 figures
Pure Flow Processing – Q3 2026 figures Sales by Customer Industry (L4Q) [in €m] Q3 25 Q3 26 Δ YoY L4Q Q3 25 L4Q Q3 26 Δ YoY Order Intake 9,5% 6,5% 500,7 548,1 2.023,8 2.155,9 0% Dairy Farming n.a Organic 1 8,3% 8,5% 21% Dairy Processing 21% YoY Sales 9,9% 6,3% Food -6% YoY 481,5 529,3 1.945,2 2.067,
Slide 24: Nutrition Plant Engineering – Q3 2026 figures
Nutrition Plant Engineering – Q3 2026 figures Sales by Customer Industry (L4Q) [in €m] Q3 25 Q3 26 Δ YoY L4Q Q3 25 L4Q Q3 26 Δ YoY Order Intake 38,6% 24,3% 453,9 629,2 1.999,4 2.485,4 11% Organic 1 37,6% 26,1% Dairy Farming n.a 0% Dairy Processing 20% YoY Sales 6,5% 2,9% Food 11% YoY 488,9 520,9 1.9
Slide 25: Pharma & Food Applications – Q3 2026 figures
Pharma & Food Applications – Q3 2026 figures Sales by Customer Industry (L4Q) [in €m] Q3 25 Q3 26 Δ YoY L4Q Q3 25 L4Q Q3 26 Δ YoY Order Intake 19,7% 3,4% 270,0 323,2 1.102,3 1.139,4 0% Dairy Farming 40% YoY Organic 1 20,2% 5,6% 23% Dairy Processing n.a Sales 3,6% 3,7% Food 1% YoY 252,0 261,0 1.042,0
Slide 26: Farm Technologies – Q3 2026 figures
Farm Technologies – Q3 2026 figures Sales by Customer Industry (L4Q) [in €m] Q3 25 Q3 26 Δ YoY L4Q Q3 25 L4Q Q3 26 Δ YoY Order Intake 5,0% 13,7% 205,1 215,4 811,1 922,0 Organic 1 4,1% 15,4% Dairy Farming 13% YoY Dairy Processing n.a Sales 10,9% 13,0% Food n.a 200,7 222,7 750,6 847,9 Organic 1 9,9% 1
Slide 27: Good order intake development
Good order intake development Order 6,500 intake rolling L4Q in €m 6,427 6,149 6,000 5,924 5,963 6,500 5,679 5,716 5,694 5,694 5,484 5,593 5,615 5,570 5,553 5,603 5,623 5,469 5,500 5,254 5,215 6,000 5,162 5,000 5,500 4,500 4,000 5,000 3,500 4,500 3,000 2,500 4,000 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23
Slide 28: Order intake split as of Q3 2026 L4Q
Order intake split as of Q3 2026 L4Q: Top 30 countries account for 87% of order intake Top DM Countries Share Delta LTM % BtB Top EM Countries Share Delta LTM % BtB United States 18% 1,16 China 8% 1,16 Germany 8% 1,08 India 3% 1,15 United Kingdom 4% 1,14 Poland 3% 0,99 Spain 4% 1,17 Algeria 2% 4,47
Slide 29: FX development
FX development FX rates Sep % total Sep YTD Δ FX YoY Sep 2026 vs Currency YTD * Sep 2025 (average) EUR 43% - - USD 19% 1,16 4% CNY 6% 7,92 -2% DKK 5% 7,47 0% GBP InsertPicture 4% 0,86 1% PLN 3% 4,27 1% CAD 2% 1,61 3% INR 2% 109,07 13% BRL 2% 5,98 -5% NZD 2% 1,98 4% AUD 1% 1,65 -5% *Share of function
Slide 30: Strong financial position and solid financial flexibility
Strong financial position and solid financial flexibility Maturity structure cash credit lines (€m) Finance KPIs End of End of €m Δ Maturity/Year Limit Utilized Comments Q3 26 Q3 25 Committed syndicated liquidity Cash and cash equivalents 390 288 back-up credit facility of 2028 650 0 Current secur
Slide 31: Additional financial information for FY 2026
Additional financial information for FY 2026 Depreciation & Financial result Tax rate Capex R&D (as % of sales) Amortization (incl. PPA, IFRS 16)1 around around between around around €230m -€30m 28-30%2 €240m 3% thereof impact from PPA around €10m 1 Before restructuring expenses I 2 Estimation does
Slide 32: Divisional guidance FY 2026 confirmed
Divisional guidance FY 2026 confirmed Revenue development (organic1) Forecast for 2026 2025 EBITDA margin before restructuring Forecast for 2026 2025 Pure Flow Processing +4.5% to +7.0% €1,953m Pure Flow Processing 27.0% to 28.5% 26.7% Nutrition Plant Engineering +7.0% to +9.0% €1,955m Nutrition Pla
Slide 33: Historical timeline (1/4)
Historical timeline (1/4) Order Intake €m Q1 24 Q2 24 Q3 24 Q4 24 FY 24 Q1 25 Q2 25 Q3 25 Q4 25 FY 25 Q1 26 Q2 26 Q3 26 PFP 504 470 455 517 1.946 507 499 501 514 2.020 551 544 548 NPE 457 466 509 662 2.094 482 402 454 835 2.172 460 561 629 PFA 259 254 238 302 1.052 268 263 270 308 1.109 274 234 323
Slide 34: Historical timeline (2/4)
Historical timeline (2/4) Order Backlog €m Q1 24 Q2 24 Q3 24 Q4 24 FY 24 Q1 25 Q2 25 Q3 25 Q4 25 FY 25 Q1 26 Q2 26 Q3 26 PFP 786 788 744 747 747 760 757 767 743 743 816 815 831 NPE 1.576 1.544 1.518 1.625 1.625 1.650 1.551 1.501 1.725 1.725 1.783 1.844 1.950 PFA 648 659 631 654 654 669 657 662 677 6
Slide 35: Historical timeline (3/4)
Historical timeline (3/4) Depreciation & amortization2 €m Q1 24 Q2 24 Q3 24 Q4 24 FY 24 Q1 25 Q2 25 Q3 25 Q4 25 FY 25 Q1 26 Q2 26 Q3 26 PFP (14) (14) (15) (16) (60) (15) (17) (16) (18) (66) (16) (17) (17) NPE (10) (10) (10) (11) (40) (10) (10) (10) (13) (42) (10) (10) (10) PFA (8) (9) (9) (17) (44)
Slide 36: Historical timeline (4/4)
Historical timeline (4/4) EBITDA margin Q1 24 Q2 24 Q3 24 Q4 24 FY 24 Q1 25 Q2 25 Q3 25 Q4 25 FY 25 Q1 26 Q2 26 Q3 26 PFP 24,7% 25,1% 24,7% 25,4% 25,0% 26,0% 27,7% 26,2% 24,8% 26,1% 26,2% 27,1% 26,3% NPE 6,7% 7,6% 11,4% 10,5% 9,2% 9,2% 9,7% 11,0% 12,8% 10,9% 7,8% 10,9% 11,6% PFA 8,5% 10,1% 10,1% 8,1
Slide 37: GEA.com
| Engineering for a better world. GEA.com